Vanta Bioscience Ltd.
Vanta Bioscience
₹ 0.00
0.00 (0.00)%
NSE
BSE
Business Support
Small-cap - With a market cap of ₹11.56 Cr.
| EX-Date | Purpose |
|---|---|
| 23 06 2021 | Preferential Issue of shares & Audited Results |
| 28 06 2021 | Preferential Issue of shares (Revised) & Audited Results |
| 11 11 2021 | Half Yearly Results |
| 30 05 2022 | Audited Results |
| 14 11 2022 | Half Yearly Results |
| 30 05 2023 | Half Yearly Results & Audited Results |
| 10 08 2023 | Half Yearly Results & Audited Results |
| 14 11 2023 | Half Yearly Results |
| 14 11 2024 | Half Yearly Results |
| 06 12 2024 | Increase in Authorised Capital Inter alia, to consider and approve:- (1) conversion of unsecured loans from Promoters and others into equity shares and increase in the authorized capital as per requirement |
| 30 05 2025 | Audited Results(Cancelled) (Cancelled) |
| 19 07 2025 | Audited Results |
| 24 07 2025 | Audited Results |
| 01 08 2025 | Audited Results |
| 14 11 2025 | Half Yearly Results |
